A novel device, currently in clinical trials at the TriHealth Heart and Vascular Institute, aims to prevent strokes by diverting blood flow away from the brain. This stent, featuring a micromesh lining, is part of the C-Guardians Two trial and represents a significant advancement in treating carotid artery disease. Early results suggest potential for this device to become a new standard of care, offering hope to patients at risk of stroke.